Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of MDD Management in Andalusia (PismaEP)

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: January 12, 2012
Last updated: August 12, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)